These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6166084)

  • 21. MLC compatibility, HLA-D and DR typing in cadaver kidney transplantations.
    Thomsen M; Morling N; Ladefoged J; Løkkegård H; Jakobsen B; Svejgaard A; Thaysen JH
    Scand J Urol Nephrol Suppl; 1980; 54():32-5. PubMed ID: 6452681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An HLA-DR negative acute leukaemia which stimulates MLC and CMC responses.
    Taylor GM; Fergusson W; Dyer PA; Harris R; Morrell G
    Cancer Immunol Immunother; 1983; 16(2):117-22. PubMed ID: 6229327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of HLA-D(DR)4 detected by primary and secondary mixed-lymphocyte-culture reactions and by individual HLA-DR4 antisera.
    Petzl ML; Scholz S; Albert ED
    Immunobiology; 1982 Aug; 162(3):265-76. PubMed ID: 6215336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of HLA-D specific primed lymphocyte typing (PLT) cells and cross-reactions of PLT-cells primed with homozygous typing cells.
    Morling N; Platz P; Ryder LP; Svejgaard A; Thomsen M
    Tissue Antigens; 1980 Feb; 15(2):137-51. PubMed ID: 12735314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The characteristics of the HLA antigens determined by cellular techniques.
    Buc M; Stefanovic J
    Allerg Immunol (Leipz); 1986; 32(1):19-25. PubMed ID: 2424294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for subtypic determinants in the HLA-DW3 cluster.
    Niese D; Grosse-Wilde H; Dupont B; Du Toit E; Johannsen R; Suciu-Foca N; Stroehmann I; Rittner C
    Hum Genet; 1978 Jul; 43(1):23-30. PubMed ID: 78887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitation of HLA-D differences.
    Suciu-Foca N; Rubinstein P; Susinno E; Broell J; Weiner J; Reemtsma K
    Tissue Antigens; 1978 Aug; 12(2):94-105. PubMed ID: 81541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-DR typing as a predictor of MLC compatibility.
    Radvany RM; Vaisrub N
    Transplantation; 1984 Oct; 38(4):347-51. PubMed ID: 6238455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A monoclonal antibody detecting an HLA-DQwl-related determinant.
    Koning F; Raghoebar J; Schreuder GM; Schuurman R; Bruning H
    Tissue Antigens; 1985 Aug; 26(2):100-9. PubMed ID: 2414859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Idiotype-like determinants on human T lymphocytes alloactivated in mixed lymphocyte culture.
    Suciu-Foca N; Rohowsky C; Kung P; King DW
    J Exp Med; 1982 Jul; 156(1):283-8. PubMed ID: 6177823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA antigens of insulin-dependent diabetics. I. PLT colonies detecting Dw10 and a new class II determinant distinct from HLA-D, DR, MB(DC), MT, and SB.
    Sheehy MJ; Quintieri FB; Yang SY; Alosco SM; Matsui Y; Yunis EJ; Gabbay KH
    Tissue Antigens; 1984 May; 23(5):290-300. PubMed ID: 6205468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Further studies on psoriasis-associated HLA-Dw/DR7 using PLT cells primed against a familial psoriasis-linked HLA haplotype.
    Marcusson JA; Möller E
    Tissue Antigens; 1986 Jan; 27(1):1-9. PubMed ID: 3082035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-D and -DR antigens on human amniotic fluid cells. I. Lack of expression of HLA-D.
    Valentine-Thon E; Kreeb G; Grosse-Wilde H; Passarge E
    Tissue Antigens; 1983 Feb; 21(2):138-47. PubMed ID: 6221440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The active rosette mixed-lymphocyte reaction: an early marker of lymphocyte activation linked to HLA-D-DR differences.
    Wybran J; Dupont E
    Clin Immunol Immunopathol; 1983 Apr; 27(1):51-5. PubMed ID: 6223752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary MLC responses of primed lymphocytes after selective sensitization to non-HLA-D determinants.
    Wank R; Schendel DJ; Blanco ME; Dupont B
    Scand J Immunol; 1979; 9(6):499-505. PubMed ID: 88755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA antigens in a psoriatic family: comparative studies with MLC, HTC, PLT and serological HLA-DR determinations.
    Marcusson J; Möller E
    Tissue Antigens; 1979 Oct; 14(4):279-95. PubMed ID: 94702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCL) as stimulating cells in mixed lymphocyte culture (MLC).
    Wasik M; Matej H; Duś D; Myc A
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):879-85. PubMed ID: 6331341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive value of HLA-DR matching for nonreactivity in mixed lymphocyte culture (MLC) depends on matching for HLA-D.
    Vaidya S; Colbaugh P; Stastny P
    Transplant Proc; 1979 Dec; 11(4):1779-80. PubMed ID: 93804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heated lymphocytes express HLA-DR antigens despite their inability to stimulate in MLC.
    Brewer JA; Hank JA; Wendel T; Schmeling GJ; Blank JL; Morrissey LW; Robins HI; Sondel PM
    Tissue Antigens; 1983 Oct; 22(4):246-56. PubMed ID: 6228035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MLC-specific suppressor T lymphocytes in man. I. Their induction in vitro by soluble HLA-DR antigens.
    Smeraldi RS; Fabio G; Bonara P; Villa MG; Vanoli M; Pettenati C; Rugarli C; Zanussi C
    J Immunol; 1982 Mar; 128(3):1394-8. PubMed ID: 6173435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.